FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044434597> ?p ?o ?g. }

• W2044434597 endingPage "371" @default.
• W2044434597 startingPage "363" @default.
• W2044434597 abstract "CONTINUED ELEVATIONS IN Intracranial Pressure (ICP) following traumatic or ischemic compromise are known to cause markedly increased morbidity and mortality. Because of the side effects of barbiturates including hypotension and prolonged recovery time, the use of shorter-acting anesthetic agents to control ICP has been considered. Etomidate, when administered by continuous infusion, has been shown to decrease cerebral metabolism resulting in a secondary decrease in cerebral blood flow with minimal changes in cerebral perfusion pressure. We initially intended to randomize 20 patients prospectively into a study protocol that would assess the effects of either pentobarbital or the cardioprotective agent etomidate on ICP and cardiac performance. Given the sequelae of the therapy, we were only able to randomize seven patients with cerebral edema refractory to medical management to receive either etomidate or pentobarbital in a blinded fashion. Three patients who received etomidate developed renal compromise (mean low creatinine clearance 41 ml/min, range 37–44 ml/min) which was initially noted at 24 hours. We believed that this represented an adverse effect that was probably related to the study drug and the study was stopped. Each patient received a 0.30 mg/kg IV induction of etomidate and then 0.02 mg/kg/min continuous infusion for 24–72 hours titrated to burst suppression. All patients also received dexamethasone 2mg IV every six hours to prevent the adrenocortical insufficiency that might occur as a consequence of etomidate-induced suppression of cortisol synthesis. Intracranial pressure decreased (mean = 12mmHg) following the initiation of etomidate. Cardiac parameters remained unchanged (cardiac output 4.8 ± .6 liters/min). We conclude that the renal compromise was likely resultant from toxic accumulation of the carrier agent propylene glycol. We suggest that the consideration of critical loads of potentially toxic carriers, such as propylene glycol, is important in future studies requiring long-term, continuous infusions." @default.
• W2044434597 created "2016-06-24" @default.
• W2044434597 creator A5037893756 @default.
• W2044434597 creator A5049265076 @default.
• W2044434597 creator A5084845946 @default.
• W2044434597 creator A5087360360 @default.
• W2044434597 date "1995-08-01" @default.
• W2044434597 modified "2023-10-15" @default.
• W2044434597 title "Propylene Glycol Toxicity Following Continuous Etomidate Infusion For The Control Of Refractory Cerebral Edema" @default.
• W2044434597 cites W1966244740 @default.
• W2044434597 cites W1968353104 @default.
• W2044434597 cites W1979509098 @default.
• W2044434597 cites W1982480866 @default.
• W2044434597 cites W1986536595 @default.
• W2044434597 cites W1999107478 @default.
• W2044434597 cites W2002669301 @default.
• W2044434597 cites W2003234731 @default.
• W2044434597 cites W2005483221 @default.
• W2044434597 cites W2014069633 @default.
• W2044434597 cites W2019383074 @default.
• W2044434597 cites W2024402949 @default.
• W2044434597 cites W2033171645 @default.
• W2044434597 cites W2034056629 @default.
• W2044434597 cites W2044472398 @default.
• W2044434597 cites W2044779196 @default.
• W2044434597 cites W2048657713 @default.
• W2044434597 cites W2055788562 @default.
• W2044434597 cites W2061444436 @default.
• W2044434597 cites W2067822784 @default.
• W2044434597 cites W2068180278 @default.
• W2044434597 cites W2068603852 @default.
• W2044434597 cites W2069273157 @default.
• W2044434597 cites W2069309433 @default.
• W2044434597 cites W2081517940 @default.
• W2044434597 cites W2089244409 @default.
• W2044434597 cites W2089471778 @default.
• W2044434597 cites W2106815203 @default.
• W2044434597 cites W2110158621 @default.
• W2044434597 cites W2112504620 @default.
• W2044434597 cites W2114049595 @default.
• W2044434597 cites W2124796109 @default.
• W2044434597 cites W2129790776 @default.
• W2044434597 cites W2135414391 @default.
• W2044434597 cites W2150151193 @default.
• W2044434597 cites W2314734007 @default.
• W2044434597 cites W2328265203 @default.
• W2044434597 cites W4236215713 @default.
• W2044434597 doi "https://doi.org/10.1227/00006123-199508000-00035" @default.
• W2044434597 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7477798" @default.
• W2044434597 hasPublicationYear "1995" @default.
• W2044434597 type Work @default.
• W2044434597 sameAs 2044434597 @default.
• W2044434597 citedByCount "71" @default.
• W2044434597 countsByYear W20444345972012 @default.
• W2044434597 countsByYear W20444345972013 @default.
• W2044434597 countsByYear W20444345972014 @default.
• W2044434597 countsByYear W20444345972015 @default.
• W2044434597 countsByYear W20444345972016 @default.
• W2044434597 countsByYear W20444345972017 @default.
• W2044434597 countsByYear W20444345972018 @default.
• W2044434597 countsByYear W20444345972020 @default.
• W2044434597 countsByYear W20444345972021 @default.
• W2044434597 countsByYear W20444345972022 @default.
• W2044434597 crossrefType "journal-article" @default.
• W2044434597 hasAuthorship W2044434597A5037893756 @default.
• W2044434597 hasAuthorship W2044434597A5049265076 @default.
• W2044434597 hasAuthorship W2044434597A5084845946 @default.
• W2044434597 hasAuthorship W2044434597A5087360360 @default.
• W2044434597 hasConcept C118552586 @default.
• W2044434597 hasConcept C126322002 @default.
• W2044434597 hasConcept C154281038 @default.
• W2044434597 hasConcept C157767197 @default.
• W2044434597 hasConcept C167639399 @default.
• W2044434597 hasConcept C2776277131 @default.
• W2044434597 hasConcept C2779493303 @default.
• W2044434597 hasConcept C2779676917 @default.
• W2044434597 hasConcept C2780954326 @default.
• W2044434597 hasConcept C42219234 @default.
• W2044434597 hasConcept C522805319 @default.
• W2044434597 hasConcept C71924100 @default.
• W2044434597 hasConcept C84393581 @default.
• W2044434597 hasConceptScore W2044434597C118552586 @default.
• W2044434597 hasConceptScore W2044434597C126322002 @default.
• W2044434597 hasConceptScore W2044434597C154281038 @default.
• W2044434597 hasConceptScore W2044434597C157767197 @default.
• W2044434597 hasConceptScore W2044434597C167639399 @default.
• W2044434597 hasConceptScore W2044434597C2776277131 @default.
• W2044434597 hasConceptScore W2044434597C2779493303 @default.
• W2044434597 hasConceptScore W2044434597C2779676917 @default.
• W2044434597 hasConceptScore W2044434597C2780954326 @default.
• W2044434597 hasConceptScore W2044434597C42219234 @default.
• W2044434597 hasConceptScore W2044434597C522805319 @default.
• W2044434597 hasConceptScore W2044434597C71924100 @default.
• W2044434597 hasConceptScore W2044434597C84393581 @default.
• W2044434597 hasIssue "2" @default.
• W2044434597 hasLocation W20444345971 @default.
• W2044434597 hasLocation W20444345972 @default.
• W2044434597 hasOpenAccess W2044434597 @default.

• next